Influence of aluminum on mineralization during matrix-induced bone development. A model of de novo mineralization employing matrix-induced endochrondral bone formation in rats was used to study the short-term effects of aluminum on the deposition of calcium and phosphate in vivo. In experiments where systemic aluminum concentrations were elevated, the cellular processes associated with bone development appeared to be normal, if somewhat delayed, however precipitation of the mineral phase was prevented. This suggests a primary direct physical chemical effect of aluminum in vivo on calcification, as suggested by in vitro studies which demonstrate that aluminum is a potent inhibitor of calcium phosphate precipitation. Aluminum salts implanted locally with the matrix appeared to be toxic to the cellular processes leading to chondrogenesis and osteogenesis.
Influence of aluminum on mineralization during matrix-induced bone development. A model of de novo mineralization employing matrix-induced endochrondral bone formation in rats was used to study the short-term effects of aluminum on the deposition of calcium and phosphate in vivo. In experiments where systemic aluminum concentrations were elevated, the cellular processes associated with bone development appeared to be normal, if somewhat delayed, however precipitation of the mineral phase was prevented. This suggests a primary direct physical chemical effect of aluminum in vivo on calcification, as suggested by in vitro studies which demonstrate that aluminum is a potent inhibitor of calcium phosphate precipitation. Aluminum salts implanted locally with the matrix appeared to be toxic to the cellular processes leading to chondrogenesis and osteogenesis.
Accumulation of aluminum (Al) in bone and the osteomalacia that develops has been described in chronic or maintenance dialyzed patients, and a direct relationship between the Al deposited and the histomorphometric changes have been reported [1-3]. Osteomalacia, osteitis fibrosa and mixed lesions were found by Hodsman et al in 59 hemodialyzed patients in whom iliac crest biopsies were performed. The highest Al content was present in the bone of the patients with osteomalacia [2] , and Al was found to be deposited at the mineralization front of the osteomalacic bone [4] . Orally administered Al hydroxide was partially absorbed and also could induce bone changes with renal insufficiency [5, 6] .
In animal studies, prolonged administration of intraperitoneal Al in rats was shown to result in an impaired mineralization of the growth plate [I], and administration of Al during four weeks induced a reduction of total bone and matrix formation, as well as of periosteal bone and matrix formation in rats with a normal renal function [7] . In addition to a direct effect of Al on bone, other studies showed systemic effects such as phosphate depletion, increase of serum calcium levels and a decrease of renal function [8, 91 . In culture, low concentrations of Al stimulated bone phosphatase activities in three-day-old calvaria, whereas at higher concentrations an inhibition was observed [10] .
Received for publication May 13, 1985 , and in revised form October 2, 1985. © 1986 by the International Society of Nephrology A previous report suggested that the impaired mineralization could be due to a direct physical chemical effect of Al ion on the precipitation of calcium phosphate [11] . This was suggested based upon the results of in vitro studies [12, 13] . The present study was undertaken to examine the effects of aluminum treatment on de novo mineralization employing the matrix-induced endochondral bone development system [14] [15] [16] during a short-term exposure in rats. This in vivo system allowed a study of the effect of Al on the calcification process to be uncomplicated by previous mineralization that had occurred as in long bone. The results demonstrate that Al, indeed, had pronounced inhibitory effects on mineralization, and these effects could be dissociated from the cellular parameters and alkaline phosphatase activity during bone development.
Methods
Demineralized bone matrix prepared from rat diaphysis was implanted subcutaneously into bilateral sites in the thoracic region of 28-day-old (110 to 120 g) male Long-Evans strain as described earlier [14] . The day of implantation was designated as day 0. On assigned days the subcutaneous button-like compact plaques were dissected, freed of adherent tissues and weighed. Representative samples were fixed in Bouins fluid for histology and 1 .tm sections were stained with toludine blue.
Systemic ejfrct of Al
Two groups of 18 rats each were studied. The experimental group received intraperitoneal injections of aluminum chloride in normal saline vehicle while the control group received only vehicle. The experimental group received a priming dose of 1 mg elemental Al/day/rat for one week before the demineralized bone matrix was implanted. Afterwards, the dose was increased to 2 mg elemental Al/day/rat for 10 and 14 days, respectively. This dose was chosen after preliminary experiments with 0.5, 1.0, and 2.0 mg doses showed maximal effect on de novo mineralization with no apparent toxicity. On day 10 and 14 after the implantation of demineralized matrix, 12 rats each (6 control and 6 experimental) were sacrificed. At the time of sacrifice, blood was collected by cardiac puncture 24 hr after the last injection for serum Al analysis. The additional animals were used for histological examination. Alkaline phosphatase and calcium uptake On the assigned days, the dissected plaques were homogenized in ice-cold 0.15 M sodium chloride containing 2 mM sodium bicarbonate and centrifuged at 20,000 g for 15 mm at 4°.
Alkaline phosphatase activity in the supernatent was determined as described earlier [14] . The presence of increased alkaline phosphatase activity (0.1 M sodium barbital buffer, pH 9.3) indicated the cellular events associated with bone formation were then occurring. The saline insoluble sediment containing the mineral fraction was washed twice with 10 muter Tris-HCI (0.005 M) and the pellets stirred for 1 hr. After centrifugation at 3000 g the supernatents were discarded. The mineral phase was dissolved in 10 mliter 0.5 M HCI by stirring overnight at 25°C. After centrifugation at 3000 g the supernatants were utilized for calcium analysis. Calcium was determined by conventional atomic absorption spectroscopy. Serum Al analysis was done by the method of Leung and Henderson [181. Calcium uptake was calculated as pg/mg of wet wt of tissue whereas alkaline phosphatase activity was expressed as units/mg protein. Plasma calcium levels were also measured on all animals. The statistical significance was evaluated by the Students (test.
Results
Serum aluminum levels for control and experimental animals after 10 and 14 days of intraperitoneal administration are given in Table 1 . As expected, Al levels were significantly higher in the experimental animals as compared to the controls. There were no differences between the plasma calcium levels in the two groups of animals.
The effects of intraperitoneal administration of Al on bone formation and mineralization are summarized in Table 2 . At 10 <0.01; ** < .001. days alkaline phosphatase was decreased in the experimental animals, however at day 14 alkaline phosphatase activity was restored to normal. Calcium uptake by the plaques was essentially completely inhibited on both day 10 and 14.
The local effect of Al is summarized in Table 3 . Alkaline phosphatase activity was significantly decreased at day 10 and 14. Calcium uptake was strongly inhibited in the extracted samples at days 10 and 14. Plasma calcium levels were not affected by the local administration of aluminum, however. The histological findings are shown in Figures 1 and 2 . The plaques dissected from the control animals on day 10 (not shown) exhibited hypertrophic chondrocytes, vascular invasion and early osteoblasts. The bone matrix formation and osteoblastic activity were normal on day 14 (Fig. 1) . In the animals which received Al intraperitoneally for 10 days, no difference from control rats was seen and it would appear that chondrogenesis was normal. Mineralization, however, was completely inhibited. The presence of chondrocytes at day 14 suggested that the overall mineralization process was somewhat delayed in the presence of elevated serum Al even though the biochemical marker of calcification, alkaline phosphatase, (Table 2), was normal. The deposition of calcium and phosphate was again completely inhibited in the day 14 plaques.
In the plaques dissected from the animals where the Al was implanted with the powder, there was no evidence of chondrogenesis or osteogenesis (Fig. 2) . The implants consisted of fibroblasts and mesenchymal cells on both days 10 (not shown) and 14. In neither the systemic nor locally implanted aluminum-treated animals was there a significant difference in the histology of tibial bones, as expected, for these short term experiments. ization and a decreased uptake of radioealeium [20] , 'l'he duration of Al administration in the present investigation was a short one, demonstrating the effect already after 10 and 14 days.
Demineralized bone matrix when implanted subcutaneously into allogenic rats induces an invarient sequence of events resulting in de novo cartilage, bone and bone marrow formation [14, 17] . The results of the present study show that aluminum has a strong inhibitory effect when implanted together with the demineralized bone powder, as well as when administered intraperitoneally, confirming a direct effect on bone.
The effect of Al on dc novo calcification, when implanted locally with the demineralized powder, would appear to be due to a direct toxic effect on the cellular processes leading to mineralization.
Both the biochemical and histological parameters showed gross abnormalities in the plaques of the aluminum-treated animals.
In contrast, the animals treated systemically with Al appeared to be not remarkably different from control animals, except that serum Al concentrations were elevated and the deposition of calcium and phosphate in the mineral phase of bone was prevented. This would tend to confirm the earlier suggestion that Al may he adversely affecting mineralization in aluminum-induced osteomalacia via a direct physical chemical effect of Al on bone mineral phases [II]. The results reported here show that chondrogenesis (day 10 plaques) appeared to proceed normally in systemic aluminum-treated animals, except for a slight reduction in alkaline phosphatase activity.
However, deposition of mineral phase did not occur. Similarly, day 14 plaques showed normal alkaline phosphatase activity suggesting normal osteogenic activity, and again, mineralization did not occur. Although the primary effect of Al on de novo calcification in this system appeared to be the physical chemical prevention of the precipitation of the mineral phase, histological examination of the developing plaques appears to suggest that elevated Al concentrations in serum also delay the cellular aspects of osteogenesis.
It should be noted that the observed results could also be due to imbalances caused by systemic Al in the levels of other factors, such as parathyroid hormone, associated with bone formation. This was not felt to be the case in the present study because of the short duration of the experiments, the relatively low doses of Al involved, and the lack of any histological evidence that bone damage occurred. In support of this was the observation that the "local" administration of Al produced a much greater impairment to de novo bone formation than the "systemic" administration, even though less than one tenth of the total Al was available for circulation. Systemic Al concentrations for the "local" experiments were not measured, however, and other complicating factors cannot be ruled out. The important consideration would seem to be that small amounts of Al appear to be capable of preventing the de novo deposition of mineral phase in the model system under study here before any effect on existing bone could be detected. This further suggests a specific effect on the initial formation of the inorganic phase.
As shown earlier [13] , the systemic concentrations of Al attained in this study (3.6 tM, day 10; 7.6 sM, day 14), especially in the presence of physiological citrate concentrations, would have a marked effect on the rate of crystallization of calcium phosphate and could seriously affect the remineralization of bone given a sufficient amount of time.
In summary, the results of this study suggest that moderately elevated concentrations of Al appear to have a selective, physical chemical effect on the deposition of calcium phosphate, largely disassociated from any biochemical or cellular event, as determined in an in vivo model of de novo bone formation. Higher local concentrations of Al, however, appear to have marked effects on all parameters associated with the mineralization process in this model.
